Advertisement
YOU ARE HERE: LAT HomeCollectionsSterling Winthrop
IN THE NEWS

Sterling Winthrop

FEATURED ARTICLES
BUSINESS
September 13, 1994 | DAVID R. OLMOS, TIMES STAFF WRITER
Bayer didn't work wonders for its previous owner. Now the German company that developed the popular painkiller in 1897 says it is regaining U.S. trademark rights that it lost after World War I and hopes to revive the brand. Bayer said Monday that it will regain the U.S. rights to the Bayer aspirin name by acquiring Sterling Winthrop's over-the-counter medication business in the United States, Canada and Puerto Rico from Britain's SmithKline Beecham for $1 billion.
ARTICLES BY DATE
BUSINESS
September 13, 1994 | DAVID R. OLMOS, TIMES STAFF WRITER
Bayer didn't work wonders for its previous owner. Now the German company that developed the popular painkiller in 1897 says it is regaining U.S. trademark rights that it lost after World War I and hopes to revive the brand. Bayer said Monday that it will regain the U.S. rights to the Bayer aspirin name by acquiring Sterling Winthrop's over-the-counter medication business in the United States, Canada and Puerto Rico from Britain's SmithKline Beecham for $1 billion.
Advertisement
BUSINESS
August 30, 1994 | From Associated Press
Eastman Kodak Co. announced Monday that it has agreed to sell its remaining Sterling Winthrop business, including non-prescription remedies such as Bayer aspirin, to health care giant SmithKline Beecham for $2.925 billion in cash. The sale is among the latest in the consolidation of the health care industry, where companies are merging to gain products and cut costs as changes cut deeply into profits. In another deal announced Monday, Ivax Corp.
BUSINESS
August 30, 1994 | From Associated Press
Eastman Kodak Co. announced Monday that it has agreed to sell its remaining Sterling Winthrop business, including non-prescription remedies such as Bayer aspirin, to health care giant SmithKline Beecham for $2.925 billion in cash. The sale is among the latest in the consolidation of the health care industry, where companies are merging to gain products and cut costs as changes cut deeply into profits. In another deal announced Monday, Ivax Corp.
BUSINESS
June 30, 1994 | From Times Staff and Wire Reports
Sanofi to Sell Winthrop for $450 Million: The drug, cosmetics and perfume unit of French oil group Elf Aquitaine said it will sell nearly all of Sterling Winthrop's diagnostic imaging business to Norway's Hafslund Nycomed for $450 million. The sale follows Sanofi's agreement last week to acquire Sterling Winthrop, the prescription pharmaceutical business of Rochester, N.Y.-based Eastman Kodak, for $1.675 billion.
BUSINESS
June 24, 1994 | From Times Wire Services
Eastman Kodak Co. said Thursday that France's Sanofi has agreed to pay more than $1.68 billion to acquire the prescription pharmaceutical business of Kodak's Sterling Winthrop subsidiary. Sanofi, Kodak's partner in the unit, was named as a potential buyer when the photographic giant said in May that it planned to sell the business. The unit includes Sterling Winthrop's stake in the Sanofi Winthrop global pharmaceutical alliance.
CALIFORNIA | LOCAL
March 20, 1989 | From Times staff and wire service reports
An experimental drug that doctors hoped would help strengthen the hearts of people with chronic heart failure appears no more effective than a long-used medication, researchers reported last week. A study involving 230 patients with chronic heart failure found those who received the drug milrinone did not do significantly better than those who received the long-used drug digoxin, the researchers said.
BUSINESS
August 11, 1994 | From Bloomberg Business News
Eastman Kodak Co. is reopening bidding for its L&F Products as it seeks separate buyers--and a higher price--for the unit's two businesses. The company said May 3 that it planned to sell L&F and two other units, Sterling Winthrop and Clinical Diagnostics, to reduce debt and concentrate on its core imaging business. L&F now plans to sell its household products business and do-it-yourself business separately, L&F President and Chief Executive Michael Gallagher told employees in a memo Wednesday.
BUSINESS
October 3, 1994 | From Associated Press
In an unusual alliance between a drug company and a nonprofit health organization, the makers of Tylenol and the Arthritis Foundation have launched a line of pain relievers aimed at the 40 million people who suffer from the crippling disease. The agreement gives the foundation $1 million a year for research, and gives Johnson & Johnson a firmer foothold in the $2.5-billion analgesic market. Tylenol, its only product in the category, is the top seller, with a market share of 33%.
BUSINESS
May 4, 1994 | JONATHAN WEBER, TIMES STAFF WRITER
Closing the books on a failed diversification strategy, Eastman Kodak Co. said Tuesday that it will sell its Sterling Winthrop drug unit and two other subsidiaries in order to pay down debt and focus resources on photography and other "imaging" businesses. The selloff is the first big initiative undertaken by Kodak Chairman George M.C. Fisher, who took the helm of the staid photography giant last fall with a vow to transform it into a major player in a variety of Information Age businesses.
BUSINESS
August 9, 1994 | From Bloomberg Business News
Eastman Kodak Co. is close to selling its household products division to one of three leading bidders: Colgate-Palmolive Co., Unilever, and Reckitt & Colman, a person familiar with the bidding said. The division, which makes Lysol cleaners and other household products, is expected to sell for $1.7 billion to $2 billion, analysts said.
HEALTH
January 24, 2000 | From Associated Press
The viruses responsible for most colds and meningitis are icosahedrons. But that is just one of the things no one knew in the early 1980s when the search began for a cure. Icosahedrons? For the non-geometry whizzes among you, that's a 20-sided solid. The quest for the drug that eventually became pleconaril started the old-fashioned way, with no clue to what rhinoviruses and enteroviruses looked like. Chemists at Sterling Winthrop Inc.
Los Angeles Times Articles
|